Daniel Beringer

Interhyp AG provides mortgage broker services. The company's brokers and consults in relation to residential mortgages, building society savings plan and insurance policies on the internet by telephone. The company was founded in 1999 by Robert Haselsteiner and Marcus Wolsdorf and is headquartered in Munich, Germany.

Thyssen Krupp Bilstein AG is a Canadian company that specializes in manufacturing steering and suspension systems for motor vehicles.

Microchip Technology Germany GmbH engages in the development, manufacture, sale, licensing, and leasing of identification, detection, warning, and access systems. It also develops, manufactures, and distributes interactive systems for information, sales, and marketing applications. The company was founded in 2002 and is headquartered in Gilching, Germany.

DOCUFY GmbH develops software solutions for technical documentation. The company is based in Bamberg, Germany. and has subsidiaries in Austria. The German company was founded in 1998 by Uwe Reißenweber. Nadine Prill has been the CEO of the company since 2022. DOCUFY was acquired by Elvaston Capital Management GmbH from Heidelberger Druckmaschinen AG on August 31, 2021.

Think.Health GmbH (Think.Health) is an independent venture capital firm founded in 2007 by Dr. Florian Kainzinger. The firm is headquartered in Fuerstenfeldbruck, Germany.

ITM Isotopen Technologien München AG develops diagnostic and therapeutic radionuclides and radiopharmaceuticals. Its products include EnolucinBeta, 188w/188re generator, 255AC/213Bi Generator, IQS-TS, IQS, consumables, and GMP Radiolabeling service. The company was founded in 2004 and is headquartered in Garching, Germany.

RV Invest GmbH provides business and economic services. The private company is based in Ravensburg, Germany. The CEOs are Udo Johannes Vetter, Gunther Strothe, Wolfgang Kerkhoff. The German company was founded in 2016.

ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011.